0346 GMT - Frencken Group's 2H revenue is likely to be broadly stable compared with 1H, UOB Kay Hian analyst John Cheong writes in a note. The technology solutions provider's 1H revenue rose 16% on year, with the semiconductor and medical segments reporting growth. The company expects these segments' 2H revenue to remain stable. However, the semiconductor segment could be weighed by factors including the ambiguity of U.S. tariffs on chips and the impact on the semiconductor-equipment sector, Cheong says. UOB KH maintains a buy rating on the stock with a target price of S$2.08. Shares are at S$1.42. (amanda.lee@wsj.com)
(END) Dow Jones Newswires
August 19, 2025 23:46 ET (03:46 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.